|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms
|
|
Structure:
|
 |
Alpha-thrombin (small subunit). Chain: l. Engineered: yes. Alpha-thrombin (large subunit). Chain: h. Engineered: yes. Cgp 50,856 inhibitor, cleaved n-terminal tripeptide fragment, d-phe-pro-arg. Chain: i.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Not given
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
J.P.Priestle,M.G.Gruetter
|
Key ref:
|
 |
J.P.Priestle
et al.
(1993).
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
Protein Sci,
2,
1630-1642.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
26-May-94
|
Release date:
|
30-Sep-94
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00734
(THRB_HUMAN) -
Prothrombin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
622 a.a.
27 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Protein Sci
2:1630-1642
(1993)
|
|
PubMed id:
|
|
|
|
|
| |
|
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
|
|
J.P.Priestle,
J.Rahuel,
H.Rink,
M.Tones,
M.G.Grütter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The three-dimensional structures of D-Phe-Pro-Arg-chloromethyl ketone-inhibited
thrombin in complex with Tyr-63-sulfated hirudin (ternary complex) and of
thrombin in complex with the bifunctional inhibitor
D-Phe-Pro-Arg-Pro-(Gly)4-hirudin (CGP 50,856, binary complex) have been
determined by X-ray crystallography in crystal forms different from those
described by Skrzypczak-Jankun et al. (Skrzypczak-Jankun, E., Carperos, V.E.,
Ravichandran, K.G., & Tulinsky, A., 1991, J. Mol. Biol. 221, 1379-1393). In
both complexes, the interactions of the C-terminal hirudin segments of the
inhibitors binding to the fibrinogen-binding exosite of thrombin are clearly
established, including residues 60-64, which are disordered in the earlier
crystal form. The interactions of the sulfate group of Tyr-63 in the ternary
complex structure explain why natural sulfated hirudin binds with a 10-fold
lower K(i) than the desulfated recombinant material. In this new crystal form,
the autolysis loop of thrombin (residues 146-150), which is disordered in the
earlier crystal form, is ordered due to crystal contacts. Interactions between
the C-terminal fragment of hirudin and thrombin are not influenced by crystal
contacts in this new crystal form, in contrast to the earlier form. In the
bifunctional inhibitor-thrombin complex, the peptide bond between Arg-Pro
(P1-P1') seems to be cleaved.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 6.
Fig. 6. Residues h55-h58 of CGP
50,856 (solid bonds) with electron
density in the exosite of thrombin
(open bonds). The 2.2 2F0 - F,, UA
(Read, 1986) electrondensitycon-
toured at 1 rms above the meanslowly
fades away beyond theamino side of
residue h55, implying that the Pro-
(Gly), linker of CGP 50,856 as well
as residuh5extends out into the sol-
vent in some disorderly fashionafter
being cleaved. The side chain fh55-
Aspcouldalsonotbeinterpreted
from the electron density.
|
 |
Figure 7.
Fig. 7. Conformation of the 149 loop
in thrombin as found in three different
crystal structures: PPACK-inhibited
thrombin (open bonds; Bode et al.,
1989), hirudin-inhibited thrombin
(striped bonds; Grutter et al., 1990),
andCGP 50,856-inhibited thrombin
(solid bonds).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the Protein Society:
Protein Sci
(1993,
2,
1630-1642)
copyright 1993.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.L.de Amorim,
P.A.Netz,
and
J.A.Guimarães
(2010).
Thrombin allosteric modulation revisited: a molecular dynamics study.
|
| |
J Mol Model,
16,
725-735.
|
 |
|
|
|
|
 |
C.C.Liu,
E.Brustad,
W.Liu,
and
P.G.Schultz
(2007).
Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.
|
| |
J Am Chem Soc,
129,
10648-10649.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.E.Bock,
P.Panizzi,
and
I.M.Verhamme
(2007).
Exosites in the substrate specificity of blood coagulation reactions.
|
| |
J Thromb Haemost,
5,
81-94.
|
 |
|
|
|
|
 |
J.L.Richardson,
B.Kröger,
W.Hoeffken,
J.E.Sadler,
P.Pereira,
R.Huber,
W.Bode,
and
P.Fuentes-Prior
(2000).
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.
|
| |
EMBO J,
19,
5650-5660.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Krishnan,
J.E.Sadler,
and
A.Tulinsky
(2000).
Structure of the Ser195Ala mutant of human alpha--thrombin complexed with fibrinopeptide A(7--16): evidence for residual catalytic activity.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
406-410.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Recacha,
M.J.Costanzo,
B.E.Maryanoff,
M.Carson,
L.DeLucas,
and
D.Chattopadhyay
(2000).
Structure of human alpha-thrombin complexed with RWJ-51438 at 1.7 A: unusual perturbation of the 60A-60I insertion loop.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
1395-1400.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Steinmetzer,
M.Renatus,
S.Künzel,
A.Eichinger,
W.Bode,
P.Wikström,
J.Hauptmann,
and
J.Stürzebecher
(1999).
Design and evaluation of novel bivalent thrombin inhibitors based on amidinophenylalanines.
|
| |
Eur J Biochem,
265,
598-605.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.De Simone,
A.Lombardi,
S.Galdiero,
F.Nastri,
R.Della Morte,
N.Staiano,
C.Pedone,
M.Bolognesi,
and
V.Pavone
(1998).
Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
|
| |
Protein Sci,
7,
243-253.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Tada,
and
J.J.Blow
(1998).
The replication licensing system.
|
| |
Biol Chem,
379,
941-949.
|
 |
|
|
|
|
 |
A.van de Locht,
W.Bode,
R.Huber,
B.F.Le Bonniec,
S.R.Stone,
C.T.Esmon,
and
M.T.Stubbs
(1997).
The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin.
|
| |
EMBO J,
16,
2977-2984.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Krishnan,
A.Tulinsky,
G.P.Vlasuk,
D.Pearson,
P.Vallar,
P.Bergum,
T.K.Brunck,
and
W.C.Ripka
(1996).
Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
|
| |
Protein Sci,
5,
422-433.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Ascenzi,
G.Amiconi,
W.Bode,
M.Bolognesi,
M.Coletta,
and
E.Menegatti
(1995).
Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: structural, functional and biomedical aspects.
|
| |
Mol Aspects Med,
16,
215-313.
|
 |
|
|
|
|
 |
A.Vindigni,
V.De Filippis,
G.Zanotti,
C.Visco,
G.Orsini,
and
A.Fontana
(1994).
Probing the structure of hirudin from Hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments.
|
| |
Eur J Biochem,
226,
323-333.
|
 |
|
|
|
|
 |
J.Vijayalakshmi,
K.P.Padmanabhan,
K.G.Mann,
and
A.Tulinsky
(1994).
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
|
| |
Protein Sci,
3,
2254-2271.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.T.Stubbs,
and
W.Bode
(1994).
Coagulation factors and their inhibitors.
|
| |
Curr Opin Struct Biol,
4,
823-832.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|